Efficacy of a paclitaxel eluting stent compared to bare nitinol stents to treat symptomatic femoropopliteal lesions: principal outcomes of the randomized EMINENT trial
Annals of Vascular Surgery(2022)
Abstract
For many experts nitinol bare stents (BMS) remain the routine treatment for femoropopliteal lesions (FP). The aim of the EMINENT study was to compare the efficacy of the Eluvia® paclitaxel eluting stent (DES) (Boston Scientific, Marlborough, MA, USA) and of BMS for the treatment of FP lesions.
MoreTranslated text
Key words
bare nitinol stents,symptomatic femoropopliteal lesions,paclitaxel
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined